Avid Bioservices Inc (CDMO)

[RRdog]

FTM

Thanks for the following:

"I am so glad to be wrong! I think RRdog is closest to the final results for MOS. Hot dog! (goes with Holy Cow!).
Can't wait to get data from pancreatic and liver cancer trials in the next few months."

Let's just hope that you be right about me being right. Then PPHM might really have something.

The key statement investors want in a PR release is that "PPHM in a 2nd line test for NSCLC has shown greater MOS than any 1st line test in NSCLC." This will be historic and unprecedented.

Best Regards,
RRdog